title: Anticoagulation in management of antiphospholipid antibody syndrome in pregnancy.
abstract: Knowledge of antiphospholipid antibodies and their impact on pregnancy continues to evolve. A variety of antiphospholipid antibodies have been identified, but not all of them seem to be pathologic for pregnancy outcome. Understanding of which patients are at high risk for adverse pregnancy outcome and the most effective treatment will require clinical trials based on risk stratification and long-term follow-up of infants.
authors.affiliation: The Barbara Volcker Center for Women and Rheumatic Disease, Hospital for Special Surgery, Weill Cornell Medical College, New York, NY 10021, USA. LockshinM@hss.edu
authors.forename: Michael D
authors.initials: MD
authors.lastname: Lockshin
mesh_terms: D000925:Anticoagulants / Q000627:therapeutic use*; D016736:Antiphospholipid Syndrome; D005260:Female; D006801:Humans; D008180:Lupus Erythematosus, Systemic; D011247:Pregnancy; D011248:Pregnancy Complications; D013927:Thrombosis
chemical_list: D000925:Anticoagulants